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ABSTRAK
Tujuan: untuk meneliti peran rasio netrofil terhadap limfosit (rasio NL) dalam memprediksi terjadinya 
adverse cardiac events selama perawatan rumah sakit pada pasien infark miokard akut dengan elevasi segmen 
ST IMA-EST. Metode: penelitian kohort pada pasien IMA-EST dengan awitan ≤24 jam yang dirawat di ICCU. 
Rasio NL dihitung sebagai hitung netrofil absolut dibagi dengan hitung limfosit absolut yang diukur melalui 
penghitung sel darah otomatis saat masuk rumah sakit. Outcome yang dinilai adalah adverse cardiac events 
selama perawatan rumah sakit yang dinilai selama follow-up. Nilai cut-off rasio NL untuk memprediksi outcome 
ditentukan berdasarkan analisis kurva ROC. Analisis univariat dan multivariat dilakukan untuk menilai apakah 
rasio NL tinggi merupakan prediktor independen untuk terjadinya adverse cardiac events selama perawatan 
rumah sakit. Hasil: dari 165 subjek, adverse cardiac events selama perawatan rumah sakit terjadi pada 49 subjek 
(29%). Nilai cut-off rasio NL adalah 6,2. Analisis univariat menunjukkan bahwa rasio NL >6,2 mempunyai 
odd ratio 3,19 (95% CI 1,55-6,55, p=0,002) untuk mengalami adverse cardiac events selama perawatan rumah 
sakit. Analisis multivariabel menunjukkan bahwa rasio NL>6,2 merupakan prediktor independen terjadinya 
adverse cardiac events selama perawatan rumah sakit dengan odd ratio 4,10 (95% CI 1,59-10,54, p=0,003). 
Kesimpulan: rasio NL yang tinggi saat masuk rumah sakit merupakan prediktor independen terjadinya adverse 
cardiac events saat perawatan rumah sakit pada pasien yang dirawat dengan IMA-EST.
Kata kunci: rasio netrofil terhadap limfosit, adverse cardiac events, infark miokard akut dengan elevasi 
segmen ST IMA-EST.
ABSTRACT
Aim: to investigate the role of neutrophil-to-lymphocyte ratio (NLratio) in predicting in-hospital adverse 
cardiac events in patients with STEMI. Methods: this was a cohort study on patients with STEMI onset ≤24 
hour hospitalised in ICCU. NLratio was calculated as absolute neutrophil count divided with lymphocyte count 
measured by automated blood cell counter on admission.The outcome was in-hospital adverse cardiac events, 
which were recorded during follow-up. The cut-off value of NLratio to predict outcome was determined by 
ROC curve analysis. Univariate and multivariable analysis to assess whether high NLratio was independent 
predictor for in-hospital adverse events were performed. Results: among165 subjects, in-hospital adverse 
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cardiac events occurred in 49 subjects (29%). The cut-off value of NLratio was 6.2. The univariate analysis 
showed that NLratio >6.2 had an odd ratio of 3.19 (95% CI 1.55-6.55, p=0.002) to develop in-hospital 
adverse cardiac events. The multivariate analysis showed that NLratio was an independent  predictor of 
in-hospital adverse cardiac events with an odd ratio of 4.10 (95% CI 1.59-10.54, p=0.003). Conclusion: high 
on-admission NLratio is an independent predictor for in-hospital adverse cardiac events in patients hospitalised 
for STEMI.
Key words: neutrophil-to-lymphocyte ratio, adverse cardiac events, STEMI.
INTRODUCTION
Acute myocardial infarction induces 
an exacerbation of acute inflammation and 
stress response, which are characterized by an 
exaggerated mobilisation of leucocytes in the 
necrotic area. Among leucocytes, neutrophils 
are mobilized the most during acute myocardial 
infarction. Elevated absolute neutrophil counts 
are associated with the development of heart 
failure and mortality in acute myocardial 
infarction.1 On the other hand, lymphocyte 
count, another differentiated type of leucocytes, 
is depressed during acute stress condition due to 
the excess of stress hormones.2 Low lymphocyte 
counts have been reported in acute myocardial 
infarction and associated with adverse clinical 
outcomes.3,4
The ratio of absolute neutrophil counts 
to lymphocyte counts (NLratio) indicates 
the equilibrium between neutrophils and 
lymphocytes in circulation.5 It reflects the state of 
acute inflammation and ongoing stress response.5 
In acute myocardial infarction, the equilibrium 
might swing to the extreme edge such that NLratio 
increases due to excessive acute inflammation 
and stress response. Increased NLratio has been 
reported in acute myocardial infarction, both 
ST-elevation myocardial infarction (STEMI) 
and NSTEMI.6,7 Most studies in patients with 
STEMI involved subjects undergoing primary 
PCI as the first treatment modality for STEMI 
in early hours.8-10 However, in real world 
situation, several patients with STEMI can 
not reach PCI-capable hospital in the duration 
allowed for primary revascularisation, therefore 
other treatment modalities are given such as 
fibrinolysis and pharmaco-intensive treatments. 
The study aims to investigate the role of 
NLratio as a predictor of in-hospital adverse 
cardiac events in patients with STEMI, either 
treated with primary revascularisation or not. 
This setting of the study is relevant in real world 
practices, since not all patients with STEMI can 
reach PCI-capable hospital to have primary PCI 
or be a candidate for fibrinolytic therapy.
METHODS
The design of the study was cohort study. 
The subjects were patients with STEMI admitted 
for intensive cardiac care hospitalisation 
in ICCU of Dr. Sardjito General Hospital, 
Yogyakarta, Indonesia. The subjects were 
recruited consecutively between August 2013 
and September 2014. The inclusion criteria were 
(1) patients with STEMI based on anginal pain, 
ST-elevation criteria in electrocardiogram and 
elevated cardiac enzyme (troponin I and/or CK-
MB), (2) patients with an onset of anginal pain 
≤ 24 hours, (3) patients with age between 30 and 
80 year old and (4) patients agreed by signing 
an informed consent. The exclusion criteria 
were (1) patients with known chronic heart 
failure, chronic kidney disease, hepatic cirrhosis, 
chronic inflammatory diseases and malignancy, 
(2) patients with concomitant acute infection 
and sepsis and (3) patients with concomitant 
acute stroke.
The diagnosis of STEMI was based on the 
criteria of ESC/ACCF/AHA/WHF.11 The onset 
of anginal pain was determined by thorough 
anamnesis with the subjects or family witnessing 
the event. Demographic data, i.e age and gender, 
was collected and recorded. Cardiovascular 
risk factors were recorded. Diabetes mellitus 
was determined as subjects with previously 
known diabetic or those taking antidiabetic 
medication on admission. Hypertension was 
determined as subjects with previously known 
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hypertension, those taking antihypertensive 
medications or those with systolic blood pressure 
≥150 and diastolic blood pressure ≥90 during 
hospitalization. Previous ischemic heart disease 
(IHD) was determined as subjects with known 
coronary artery disease, either stented or non 
stented, or previous hospitalisation of acute 
coronary syndrome or those taking antiischemic 
medication and antiplatelets. Chronic heart 
failure, chronic kidney disease, hepatic cirrhosis 
and malignancy were diagnosed by anamnesis 
of previous illnessess. Chronic inflammatory 
diseases was determined as rheumatoid arthritis, 
inflammatory bowel disease or psoriasis, which 
was known through anamnesis. Acute infection 
was determined as fever and known focal 
infection, whereas sepsis were determined based 
on standard criteria and confirmed by an internist 
in consultation. Acute stroke was determined as 
an infarct or hemorrhage stroke, confirmed by a 
neurologist in consultation.
Blood was collected from antecubital veins 
in supine position in each subject, centrifuged 
and inserted into an automated blood cell 
counter. Total leucocyte count and differential 
subtype counts, including absolute neutrophil 
and lymphocyte counts, were analyzed using 
an automated blood cell counter in hospital 
laboratory. The neutrophil to lymphocyte 
ratio (NLratio) was calculated as the absolute 
neutrophil count divided with lymphocyte 
count. Other routine laboratory examination 
was performed. Blood collection was done 
on admission before revascularisation and 
heparinisation therapy started.
The follow-up was conducted within 
hospitalisation timeframe. Adverse cardiac events 
were determined as in-hospital mortality, acute 
heart failure, cardiogenic shock, resuscitated 
cardiac arrest and reinfarction. In-hospital 
mortality was all cause of death during intensive 
hospitalization. Acute heart failure was the 
presence of symptom of breathlesness and 
fatique and signs of congestion with subsequent 
use of intravenous diuretics. Cardiogenic shock 
was low blood pressure (systolic blood pressure 
< 90 mmHg) and signs of low perfusion with 
subsequent use of vasopressor. Reinfarction 
was defined as recurrent chest pain, recurrent 
ST-segment elevation and a re-elevation of 
creatinekinase-MB. The adverse cardiac events 
were confirmed by attending cardiologists as 
well as the subsequent treatment of the events 
were in the discretion of attending cardiologist 
treating the patients.
Subjects were participated voluntarily 
and confirmed with an informed consent. The 
Medical and Health Research Ethics Committee 
Faculty of Medicine Universitas Gadjah Mada 
and Dr. Sardjito Hospital approved the study 
protocol and released the ethical clearance.
For statistics analysis, the SPSS 16.0 
software was used. Continuous data was checked 
for normality distribution with Kolmogorov-
Smirnov test. Comparison between normally 
distributed continuous data was performed 
with student’s T-test, while Mann-Whitney 
test was used for not normally distributed 
continuous data after logarithmic transformation. 
Comparison between categorical data was 
performed with Chi-square test. Receiver-
operating characteristics (ROC) curve analysis 
was performed to determine the cut-off value 
of NLratio in respect to in-hospital adverse 
cardiac events. Univariate and multivariable 
analysis were performed to variables which 
displayed statistics difference between groups 
with p<0.200. Logistic regression method was 
used as a multivariable analysis to determine the 
independent predictors among variables entered 
in the models. A scoring system was developed 
based on multivariate analysis. A value of p<0.05 
was determined as statistical significancy.
RESULTS
A number of 165 subjects were recruited 
in this study, comprised of 131 male subjects 
(79%) with mean age of 58.1 years. Twenty-
seven percent of subjects had diabetes mellitus, 
69% had hypertension and 12% had previous 
ischemic heart disease. Fifty percent of subjects 
were smokers who still smoked actively 
when the infarct event occurred. The subjects 
characteristics were shown in Table 1.
Twenty-seven subjects (16 %) presented with 
Killip class II-IV on admission. Revascularisation 
procedure was accomplished in 118 subjects 
Anggoro B. Hartopo                                                                                                         Acta Med Indones-Indones J Intern Med
6
(72%), consisted of 53 fibrinolysis (32%) and 
61 primary PCIs (36%). Anticoagulant therapy 
during hospitalisation was administered in 
153 subjects (93%), either with unfractionated 
heparin, low molecular weight heparin or 
fondaparinux. ACE inhibitor was given to 127 
subjects (77%), whereas beta blocker was given 
to 87 subjetcs (53%).
Adverse cardiac events during hospitalisation 
occured in 49 subjects (29%). Compared with 
subjects without in-hospital adverse cardiac 
events, those with adverse cardiac events were 
more likely to be female (p=0.039 vs. male), 
have diabetes mellitus (p=0.031), be non smoker 
(p=0.012), have worse Killip class (p=0.001), 
have lower hemoglobin level (p=0.003), have 
higher absolute neutrophil count (p=0.007) and 
have higher blood creatinine and glucose levels 
(p=0.014 and p<0.001, respectively). The value of 
NLratio was significantly higher in subjects with 
in-hospital adverse cardiac events as compared to 
those without events (p<0.001). The parameters 
between two groups are shown in Table 1.
Receiver-operating characteristics curve 
(ROC) analysis showed that NLratio had an area 
under the curve (AUC) of 66% to predict the 
adverse cardiac events, as shown in Figure 1. 
Using this curve, the cut-off value of NLratio was 
set in the point of 6.2, which gave the sensitivity 
of 71% and specificity of 56%. Therefore, subjects 
with NLratio >6.2 was grouped and analysed with 
univariate and multivariable analysis.
Table 1. Baseline characteristic between subjects with and without in-hospital adverse cardiac events
Parameters All subjects (n=165) Adverse cardiac events (n=49)
No adverse cardiac 
events (n=116) p value**
Age (year), mean±SD 58.1±9.1 58.9±8.8 57.7±9.2 0.446
Male gender, n (%) 131 (79) 34 (69) 97 (84) 0.039
Diabetes mellitus, n (%) 45 (27) 19 (39) 26 (22) 0.031
Hypertension, n (%) 107 (69) 33 (67) 74 (64) 0.662
Previous IHD, n (%) 19 (12) 6 (12) 13 (11) 0.849
Current smoker, n (%) 82 (50) 17 (35) 65 (56) 0.012
Body mass index* 23.4 (3.8) 23.4 (5.1) 23.4 (3.4) 0.763
Killip II-IV, n (%) 27 (16) 15 (31) 12 (10) 0.001
Hemoglobin (g/dL), mean±SD 13.7±1.9 13.0±2.0 13.9±1.7 0.003
Leucocyte (x103/mm3), 
mean±SD
13.2±3.9 14.1±3.9 12.8±3.9 0.067
Neutrophil (x103/mm3), 
mean±SD 
10.3±3.9 11.5±3.6 9.7±3.9 0.007
Lymphocyte (x103/mm3), 
mean±SD
1.8±0.9 1.7±1.0 1.9±0.8 0.201
NLratio* 6.6 (4.7) 7.9 (4.8) 5.7 (4.1) 0.001
Creatinine (mg/dL), mean±SD 1.1 (0.47)* 1.5±0.9 1.1±0.4 0.014
Glucose (mg/dL)* 184.3±96.7 202.0 (181.0) 137.0 (53.7) <0.001
Fibrinolysis, n (%) 53 (32) 17 (35) 36 (31) 0.646
Primary PCI, n (%) 61 (36) 23 (47) 38 (33) 0.089
Heparin, n (%) 0.537
 - Unfractionated 128 (77) 38 (78) 90 (77)
 - Low molecular weight 13 (8) 2 (4) 11 (10)
 - Fondaparinux 12 (7) 5 (10) 7 (6)
ACE inhibitor, n (%) 127 (77) 35 (71) 92 (79) 0.272
Beta blocker, n (%) 87 (53) 22 (45) 65 (56) 0.317
* Data not normally distributed, value was depicted in median (interquartile range) and analysed with Mann-Whitney U 
test, ** A p value from analysis between subject with and without in-hospital adverse cardiac events
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The characteristics of subjects based on the 
value of NL ratio are shown in Table 2. The 
amount of subjects with NL ratio >6.2 was 86 
subjects while the subjects with NL ratio ≤6.2 
was 79 subjects.
The univariate analysis showed that NLratio 
>6.2 had an odd ratio of 3.19 (95% CI 1.55-6.55, 
p=0.002) to develop adverse cardiac events 
as compared NLratio <6.2. The multivariable 
analysis using logistic regression methods was 
performed with the adjustment of variables 
having p<0.200 in difference between groups 
(Table 3). The result of logistic regression 
analysis showed that NLratio was an independent 
predictor of in-hospital adverse cardiac events 
with an odd ratio of 4.10 (95% CI 1.59-10.54, 
p=0.003). Other independent predictors in this 
model were Killip class II-IV (odd ratio of 4.74 
(95% CI 1.67-13.48, p=0.003) and creatinine 
>1.3 mg/dL (odd ratio of 4.53 (95% CI 1.83-
11.17, p=0.001). The result of univariate and 
mutivariable analysis is shown in Table 3.
Based on multivariate analysis, the scoring 
system was developed incorporating variables 
with p value <0.05, i.e NL ratio >6.2, creatinine 
>1.3 and Killip class II-IV (Table 3). The total 
score was 9, out of three variables. We generated 
three risk category (low risk (score 0-2), medium 
risk (3-5) and high risk (6-9). (Table 4)
Figure 1. Receiver-operating characteristics curve (ROC) 
analysis gave NLratio cut-off value of 6.2 with sensitivity 71% 
and specificity 56% for in-hospital adverse cardiac events
Table 2. The characteristics of subjects according to the 
value of NL ratio
Parameters NL ratio ≤6.2(n=79)
NL ratio >6.2
(n=86)
Age (year), mean±SD 57.7±9.8 58.4±8.3
Male gender, n (%) 66 (84) 65 (76)
Diabetes mellitus, n (%) 23 (29) 22 (26)
Hypertension, n (%) 49 (62) 58 (67)
Previous IHD, n (%) 12 (15) 7 (8)
Current smoker, n (%) 38 (48) 44 (51)
Body mass index* 23.5 (3.4) 23.8 (3.4)
Killip II-IV, n (%) 13 (17) 14 (16)
Hemoglobin (g/dL), 
mean±SD
13.9±1.7 13.5±2.0
Leucocyte (x103/mm3), 
mean±SD
11.6±3.5 14.5±3.9
Neutrophil (x103/mm3), 
mean±SD 
8.0±3.0 12.4±3.4
Lymphocyte (x103/
mm3), mean±SD
2.4±1.1 1.3±0.4
NLratio* 4.2 (2.9) 8.8 (3.5)
Creatinine (mg/dL), 
mean±SD
1.4±2.0 1.2±0.4
Glucose (mg/dL)* 137.0 (83.0) 157.0 (120.7)
Fibrinolysis, n (%) 26 (33) 27 (31)
Primary PCI, n (%) 21 (27) 40 (46)
Heparin, n (%)
 - Unfractionated 62 (78) 66 (77)
 - Low molecular 
weight
9 (11) 4 (5)
 - Fondaparinux 5 (6) 7 (8)
ACE inhibitor, n (%) 60 (761) 67 (78)
Beta blocker, n (%) 46 (58) 41 (48)
* Data not normally distributed, value was depicted in 
median (interquartile range)
DISCUSSION
The result of this study shows that higher 
NLratio, with cut-off value 6.2, is an independent 
predictor of in-hospital adverse cardiac events 
in patients with STEMI. Patient with NLratio 
>6.2 had a four-time risk to develop in-hospital 
adverse cardiac events. Along with established 
predictors, i.e. Killip class and creatinine 
>1.3 mg/dl, on admission NL ratio >6.2 pose 
an increasing risk of hospital mortality and 
complication among patients admitted for 
STEMI, either primary revascularised or non-
revascularised.
Other studies showed that high value of 
NLratio is associated with in-hospital major 
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adverse cardiac events in STEMI patients 
regardless primary revascularisation therapy, i.e. 
primary PCI or fibrinolysis.6 Nunez et al. (2008) 
revealed that the high quintile value of NLratio 
were associated with in-hospital mortality and a 
worse clinical picture during hospitalisation such 
as worse Killip class, left ventricular dysfunction, 
higher arrhytmia, maximum troponin I level and 
the need for rescue PCI in patients with STEMI.6 
This study showed that increased NLratio 
occurred from hospital admission and reached 
its peak level in 12-14 hour after admission.
Most studies on the role of NLratio in STEMI 
patients involving those whom treated with 
primary PCI as a the first principal treatment 
strategy. Arbel et al.8 (2014) showed that high 
NLratio was independently associated with 
lower ejection fraction, cardiogenic shock 
and acute kidney failure in STEMI patients 
referred for primary PCI. However, acute heart 
failure did not associated with high NLratio 
according to the study.8 Among STEMI patients 
with primary PCI, high NLratio associated 
with no re-flow following PCI and subsequent 
in-stent thrombosis, in-hospital mortality and 
major adverse cardiac events.12-14 In our study, 
primary revascularisation procedure was 
accomplished in 114 subjects (71%), i.e. primary 
PCI in 61 subjects (36%) and fibrinolysis in 
53 subjects (32%). Combined with subjects 
without undergoing primary revascularisation, 
high NLratio increases the risk for in-hospital 
adverse outcome.
Similar to our study, Ghaffari et al.15 (2014) 
enrolled about 400 patients with STEMI regardless 
of primary revascularisation and reported the 
increasing incidence of left ventricular pump 
failure and major tachyarrhytmias. The study 
reported the incidence of in hospital cardiac 
events occurred in the first day of hospitalisation, 
which implicated the direct impact of NL ratio 
which was measured on admission. In our study, 
the adverse cardiac events were also observed 
from early hospitalisation. Furthermore, our 
study showed NL ratio predicted adverse cardiac 
events independently to Killip class which was 
determined on admission.
In STEMI patients, a higher NL ratio is 
associated with the severity of coronary artery 
disease and predicted higher Syntax score on 
coronary angiography analysis. This relationship 
is independent with other predictors such as 
diabetes mellitus, age and ejection fraction.16 
This may implicate the role of NL ratio as one of 
the supporting factor in coronary atherosclerosis 
development. Not only in acute phase of coronary 
artery disease, higher NL ratio also implicates 
Table 3. Univariate and multivariable analysis among variables to predict in-hospital adverse cardiac events
Variables
Univariate Multivariate
Unadjusted OR  
(95% CI) P value
Adjusted OR  
(95% CI) P value
Male gender 2.25 (1.03-4.92) 0.042 1.12 (0.35-3.59) 0.850
Diabetes mellitus 2.19 (1.07-4.51) 0.033 1.31 (0.51-3.34) 0.576
Current smoker 0.42 (0.21-0.83) 0.013 0.43 (0.16-1.17) 0.099
Killip II-IV 3.82 (1.63-8.97) 0.002 4.74 (1.67-13.48) 0.003
Hemoglobin 1.32(1.09-1.59) 0.005 0.86 (0.67-1.09) 0.218
Leucocyte 0.93(0.85-1.01) 0.070 1.05 (0.94-1.18) 0.380
NLratio>6.2 3.19(1.55-6.55) 0.002 4.10 (1.59-10.54) 0.003
Creatinine>1.3 3.68(1.80-7.55) <0.001 4.53 (1.83-11.17) 0.001
Reactive hyperglycemia 3.07(1.48-6.38) 0.003 1.62 (0.67-3.94) 0.283
Primary PCI 1.76(0.89-3.47) 0.103 1.00 (0.44-2.27) 0.994
Table 4. Scoring system based on multivariate analysis
Variables Score
Killip II-IV 3
Creatinine >1.3 3
NLratio >6.2 3
Total score 9
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on the presence and severity of coronary artery 
disease in stable coronary artery disease.17 The 
severity of coronary artery disease, in addition 
to culprit vessel, affects the outcome of STEMI 
both in hospital or long term prognosis.
NLratio is combined value of neutrophil 
count as an inflammatory marker and lymphocyte 
count as a stress response marker. The neutrophils 
release inflammatory mediators and orchestrate 
tissue inflammation. Increased neutrophil count 
is associated with the acute inflammatory 
response due to tissue injury or infarction. During 
myocardial infarction, neutrophil mobilisation 
aims as a repair process of an infarcted myocardia, 
however several maladaptive processes occur and 
contribute a worse clinical outcome.6 Maladaptive 
impacts of neutrophil mobilisation for instances 
intravascular plugging, extensive myocardial 
necrosis, reperfusion injury, oxidative stress, 
plaque infiltration and disruption and neutrophil-
platelet interaction.6 In contrast, low lymphocyte 
count in myocardial infarction contribute to 
increased circulating apoptotic lymphocytes that 
induce secretion of inflammatory cytokines.13 
Taken together, higher NLratio reflects the 
increasing acute inflammation and ongoing stress 
that cause maladaptive responses during acute 
phase of infarct myocardial.
Our study clearly showed that high NLratio is 
associated with a 4-fold increased risk to develop 
in-hospital adverse events in patients with 
STEMI. The risk encompassess both primary 
revascularised and non-revascularised patients. 
The result of our study conveys additional 
evidence that NLratio measurement on admission 
in STEMI is necessary to predict subsequent 
worsened event. Measurement of NLratio is 
routinely done in the first blood withdrawal for 
routine laboratory examination, therefore no 
additional cost or effort is needed. This simple 
and practical examination is available in all 
hospital treating patients with STEMI.
CONCLUSION
A high NLratio on-admission is an 
independent predictor for in-hospital adverse 
cardiac events in patients hospitalised for 
STEMI.
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